Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome in adults prognostic factors for outcomes

Meng Yu Wu, Chung Chi Huang, Tzu I. Wu, Chin Liang Wang, Pyng Jing Lin

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Despite a therapeutic option for severe acute respiratory distress syndrome (ARDS), the survival benefit of venovenous extracorporeal membrane oxygenation (VV-ECMO) is still controversial in adults. This study was aimed at investigating the prognostic factors for ECMO-treated ARDS in adult patients. From 2012 to 2015, 49 patients (median age: 57 years) received VVECMO in our institution and were included in this retrospective study. The indication of VV-ECMO was a severe hypoxemia (PaO2/FiO2 ratio 35cmH2O and a FiO2 >0.8. To decrease the impact of pulmonary injuries associated with the high-pressure ventilation, the settings of MV on VV-ECMO were downgraded accorDing to our protocol. Outcomes of this study were death on VV-ECMO and death in hospital. Important demographic and clinical data during the treatment were collected for outcome analyses. All patients experienced significant improvements in arterial oxygenation onVV-ECMO.Twenty-four hours after initiation ofVV-ECMO, the median PaO2/FiO2 ratio increased from 58 to 172mmHg (P90 hours was the prognostic factor of death before hospital discharge (OR: 7, 95% CI: 1-29, P

Original languageEnglish
Article numbere2870
JournalMedicine (United States)
Volume95
Issue number8
DOIs
Publication statusPublished - Mar 4 2016

Fingerprint

Extracorporeal Membrane Oxygenation
Adult Respiratory Distress Syndrome
Severe Acute Respiratory Syndrome
Lung Injury
Ventilation
Retrospective Studies
Demography
Outcome Assessment (Health Care)
Pressure
Survival
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome in adults prognostic factors for outcomes. / Wu, Meng Yu; Huang, Chung Chi; Wu, Tzu I.; Wang, Chin Liang; Lin, Pyng Jing.

In: Medicine (United States), Vol. 95, No. 8, e2870, 04.03.2016.

Research output: Contribution to journalArticle

@article{036c21ea3d73435db8eebaee79b06509,
title = "Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome in adults prognostic factors for outcomes",
abstract = "Despite a therapeutic option for severe acute respiratory distress syndrome (ARDS), the survival benefit of venovenous extracorporeal membrane oxygenation (VV-ECMO) is still controversial in adults. This study was aimed at investigating the prognostic factors for ECMO-treated ARDS in adult patients. From 2012 to 2015, 49 patients (median age: 57 years) received VVECMO in our institution and were included in this retrospective study. The indication of VV-ECMO was a severe hypoxemia (PaO2/FiO2 ratio 35cmH2O and a FiO2 >0.8. To decrease the impact of pulmonary injuries associated with the high-pressure ventilation, the settings of MV on VV-ECMO were downgraded accorDing to our protocol. Outcomes of this study were death on VV-ECMO and death in hospital. Important demographic and clinical data during the treatment were collected for outcome analyses. All patients experienced significant improvements in arterial oxygenation onVV-ECMO.Twenty-four hours after initiation ofVV-ECMO, the median PaO2/FiO2 ratio increased from 58 to 172mmHg (P90 hours was the prognostic factor of death before hospital discharge (OR: 7, 95{\%} CI: 1-29, P",
author = "Wu, {Meng Yu} and Huang, {Chung Chi} and Wu, {Tzu I.} and Wang, {Chin Liang} and Lin, {Pyng Jing}",
year = "2016",
month = "3",
day = "4",
doi = "10.1097/MD.0000000000002870",
language = "English",
volume = "95",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome in adults prognostic factors for outcomes

AU - Wu, Meng Yu

AU - Huang, Chung Chi

AU - Wu, Tzu I.

AU - Wang, Chin Liang

AU - Lin, Pyng Jing

PY - 2016/3/4

Y1 - 2016/3/4

N2 - Despite a therapeutic option for severe acute respiratory distress syndrome (ARDS), the survival benefit of venovenous extracorporeal membrane oxygenation (VV-ECMO) is still controversial in adults. This study was aimed at investigating the prognostic factors for ECMO-treated ARDS in adult patients. From 2012 to 2015, 49 patients (median age: 57 years) received VVECMO in our institution and were included in this retrospective study. The indication of VV-ECMO was a severe hypoxemia (PaO2/FiO2 ratio 35cmH2O and a FiO2 >0.8. To decrease the impact of pulmonary injuries associated with the high-pressure ventilation, the settings of MV on VV-ECMO were downgraded accorDing to our protocol. Outcomes of this study were death on VV-ECMO and death in hospital. Important demographic and clinical data during the treatment were collected for outcome analyses. All patients experienced significant improvements in arterial oxygenation onVV-ECMO.Twenty-four hours after initiation ofVV-ECMO, the median PaO2/FiO2 ratio increased from 58 to 172mmHg (P90 hours was the prognostic factor of death before hospital discharge (OR: 7, 95% CI: 1-29, P

AB - Despite a therapeutic option for severe acute respiratory distress syndrome (ARDS), the survival benefit of venovenous extracorporeal membrane oxygenation (VV-ECMO) is still controversial in adults. This study was aimed at investigating the prognostic factors for ECMO-treated ARDS in adult patients. From 2012 to 2015, 49 patients (median age: 57 years) received VVECMO in our institution and were included in this retrospective study. The indication of VV-ECMO was a severe hypoxemia (PaO2/FiO2 ratio 35cmH2O and a FiO2 >0.8. To decrease the impact of pulmonary injuries associated with the high-pressure ventilation, the settings of MV on VV-ECMO were downgraded accorDing to our protocol. Outcomes of this study were death on VV-ECMO and death in hospital. Important demographic and clinical data during the treatment were collected for outcome analyses. All patients experienced significant improvements in arterial oxygenation onVV-ECMO.Twenty-four hours after initiation ofVV-ECMO, the median PaO2/FiO2 ratio increased from 58 to 172mmHg (P90 hours was the prognostic factor of death before hospital discharge (OR: 7, 95% CI: 1-29, P

UR - http://www.scopus.com/inward/record.url?scp=84962563334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962563334&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000002870

DO - 10.1097/MD.0000000000002870

M3 - Article

C2 - 26937920

AN - SCOPUS:84962563334

VL - 95

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 8

M1 - e2870

ER -